Material Type

• Blood (whole) (3)
• Dried whole blood (2)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Pathogen DNA (Derivative) (2)
• Plasma (single spun) (5)
• Saliva (2)
• Serum (4)
• Stool (2)
• Swab medium (4)

Microscopic Assessment

• Affected (1)
• Not applicable (7)

Storage Temperature

• RT (1)
• -35°C to -18°C (3)
• -85°C to -60°C (5)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (4)
• Followup records (4)
• Freezer temperature logs (4)
• Genomic datasets (1)
• Imaging data (2)
• Microbiological results (3)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (3)
• Pre-analytical data (4)
• Primary care records (1)
• Quality indicators (4)
• Survey data (5)
• Treatment records (2)

Timeframe

• Immediate (2)
• 0 - 3 months (4)
• 3 - 6 months (1)
• > 6 months (3)

Participant Count

• 11 - 100 (2)
• 101 - 500 (6)
• 501 - 1000 (1)
• 10001 - 50000 (1)

Sex

• Both sexes (8)

Age Range

• Young adult (18 - 40 years) (8)

Biobank Services

• Ability to recontact (3)
• Cell culture (2)
• Data analytics (3)
• Infectious strain isolation (2)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Case-control (1)
• Cross-sectional (2)
• Disease specific (5)
• Population-based (1)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (8)
• No Genetic analysis restriction (8)
• No Human genetic analysis restriction (6)
• No restrictions (2)
• No Project specific restriction (7)
• No Scope of use restriction (5)

Collection Status

• In progress (8)

Access Condition

• Open to applicants (2)
• Open only through collaboration (3)
• Access restricted at present (3)

Country

• Brazil (1)
• Côte d'Ivoire (1)
• India (1)
• Peru (1)
• South Africa (1)
• Uganda (2)
• United States (1)

County